Chronic Arachnoiditis

Chronic arachnoiditis means long-lasting inflammation and scarring of the arachnoid, a thin covering around the spinal cord and nerve roots. Over time, the inflamed tissues can stick together (adhere), trapping or clumping the nerve roots. This can block or disturb the normal flow of spinal fluid and irritate nerves, causing burning nerve pain, electric-shock sensations, back and leg pain, numbness, weakness, problems with bladder or bowel control, and sometimes sleep and mood problems. The condition often follows spinal surgery, injections into the spine, infections, bleeding, or trauma, but sometimes no clear cause is found. It is rare, often missed, and there is no single “cure,” so treatment focuses on reducing pain, improving function, protecting nerves, and supporting mental health with a team approach. NINDS+1

Chronic arachnoiditis is long-lasting inflammation and scarring of the arachnoid—the middle, delicate covering around the spinal cord and nerve roots. When this thin membrane becomes inflamed, the nerves in the spinal canal can swell, stick together, or get trapped by scar tissue (adhesions). Over time, this can disturb the flow of spinal fluid, tug on nerves, and cause ongoing back and leg pain, tingling, weakness, bladder or bowel problems, and other nerve symptoms. Doctors often confirm the diagnosis with MRI scans that show tell-tale signs such as clumping or “sticking” of nerve roots or an “empty” appearance of the fluid sac because the roots are plastered to the wall. There is no single cure, so care focuses on managing pain, improving function, and preventing worsening. NCBI+2Radiopaedia+2

Other names

Doctors may use different names that point to the same or closely related problem. These include: “adhesive arachnoiditis” (emphasizes scarring and sticking), “spinal arachnoiditis,” “chronic adhesive arachnoiditis,” “arachnoiditis ossificans” (rare form with calcification), “post-operative arachnoiditis,” and “cauda equina arachnoiditis.” You might also see imaging phrases like “nerve root clumping,” “empty thecal sac sign,” or “loculated arachnoid cysts,” which describe what the radiologist sees on MRI. Radiopaedia+2Radiopaedia+2

Types

Clinicians often describe types by what MRI shows inside the spinal canal:

• Type I: Nerve roots are bunched up or “clumped,” but still near the center of the sac. This suggests early adhesions with distorted root positions. Radiopaedia

• Type II (“empty thecal sac”): Roots are stuck to the outer wall of the sac, so the middle looks “empty” on MRI. This implies more advanced scarring. Radiopaedia+1

• Type III: Nerve roots are massed together into a central soft-tissue bundle, sometimes with septations or cyst-like pockets that trap fluid. This is severe, chronic adhesive disease. Radiopaedia+1

Causes

1. Spine surgery — Any operation on the lower back or spine can irritate the arachnoid, introduce blood products, or trigger scarring later, leading to chronic inflammation. Cleveland Clinic+1

2. Infections — Bacteria, tuberculosis, fungi, or viruses can inflame the arachnoid and leave scarring even after the infection is controlled. sfn.org

3. Subarachnoid hemorrhage (bleeding around the cord) — Blood is irritating to the arachnoid; breakdown products can cause delayed scarring and tethering. Nature

4. Spinal trauma — Direct injury, fracture, or post-traumatic bleeding can spark a non-infectious, persistent inflammatory response. PubMed Central

5. Prior myelography (older oil-based contrast) — Historic contrast agents were irritating and caused many cases before MRI became routine. Cleveland Clinic

6. Epidural or intrathecal steroid procedures — Rarely, injections or additives can irritate or chemically inflame the arachnoid. Cleveland Clinic

7. Repeated spinal procedures — Multiple punctures, catheterizations, or pain interventions can cumulatively injure the arachnoid in susceptible people. PubMed

8. Degenerative disc disease with chronic nerve compression — Long-term mechanical irritation and inflammation around roots may contribute. sfn.org

9. Spinal canal narrowing (stenosis) — Narrow spaces can crowd and rub nerve roots, promoting inflammation and adhesions. Radsource

10. Arachnoid cysts and septations — Pockets within the arachnoid can trap fluid and tether roots; cyst-lining inflammation fuels scarring. NCBI

11. Autoimmune or inflammatory disorders — Systemic inflammation (e.g., some rheumatic diseases) can involve the meninges and trigger arachnoiditis. PubMed

12. Chemical irritation — Antiseptics, preservatives, or other chemicals inadvertently introduced into the thecal sac can inflame the arachnoid. PubMed

13. Spinal tumors or prior tumor surgery — Tumors or their removal can bleed or inflame meninges and seed adhesions afterward. PubMed

14. Chronic cerebrospinal fluid (CSF) leaks or low-pressure states — Pressure changes may promote meningeal inflammation in some cases. (Mechanistic inference from meningeal irritation literature; clinicians consider this in complex pain workups.) PubMed

15. Post-meningitis scarring — After bacterial or fungal meningitis, residual meningeal scarring can extend into the spinal arachnoid. sfn.org

16. Previous instrumentation (hardware) — Screws, rods, or shunts may indirectly lead to local inflammation around the canal. PubMed

17. Surgery for disc herniation or laminectomy — Tissue handling and bleeding during decompression can precipitate later adhesions. ScienceDirect

18. Radiation (rare, historic reports) — Radiation can thicken leptomeninges and provoke adhesive change in older case literature. Radiological Society of North America

19. Idiopathic (no clear cause) — In some patients, no single trigger is found; inflammation seems to arise without a known event. PubMed Central

20. Post-aneurysmal SAH with syringomyelia — Rarely, delayed spinal arachnoiditis follows aneurysm bleeding and may contribute to cysts within the cord. Nature

Common symptoms

1. Chronic low back pain — The most frequent complaint; pain comes from inflamed, tethered nerve roots and irritated meninges. StatPearls

2. Leg pain (radicular pain/sciatica-like) — Sticking and crowding of roots can send sharp or burning pain down one or both legs. StatPearls

3. Tingling, pins-and-needles, or numbness — Damaged sensory fibers misfire or go silent, creating abnormal skin sensations. StatPearls

4. Weakness — Motor roots can conduct poorly when inflamed or tethered, causing foot drop or difficulty climbing stairs. StatPearls

5. Worsening pain with activity or certain positions — Stretching tethered roots can provoke flares; people learn to avoid triggers. sfn.org

6. Stiffness or limited spinal motion — Pain and fear of flares reduce movement, leading to stiffness over time. sfn.org

7. Bladder problems — Urgency, retention, or leakage can appear if sacral roots are affected. Verywell Health

8. Bowel problems — Constipation or incontinence may occur in more advanced cases. Verywell Health

9. Sexual dysfunction — Erectile dysfunction or reduced sensation can reflect sacral nerve involvement. Verywell Health

10. Burning pain — Many describe electrical or burning qualities typical of nerve injury pain. Cleveland Clinic

11. Allodynia (pain from light touch) — Touched skin over the painful area can feel unusually sensitive. StatPearls

12. Fatigue and poor sleep — Chronic pain commonly disrupts sleep, which worsens next-day pain and function. (General chronic pain mechanism; included by consensus in reviews.) PubMed

13. Balance issues — Weakness, numbness, and pain can alter gait and balance. PubMed

14. Muscle cramps or spasms — Irritated roots and guarding can lead to cramping in the calves or back muscles. PubMed

15. Symptom flares — Weather, stress, prolonged sitting, or sudden movement can trigger short spikes of pain due to tethered roots. PubMed

Diagnostic tests

A) Physical examination

1. Gait and posture check — The clinician watches how you stand and walk to see if pain, weakness, or numb feet change your steps. Asymmetry, short stride, or guarded motion can hint at root irritation. StatPearls

2. Neurologic screening — Strength, reflexes, and sensation are tested in each leg to map out which roots might be inflamed or stuck. Patterned losses guide imaging. StatPearls

3. Straight-leg raise (SLR) — Lifting the leg stretches the sciatic nerve roots. Worsening leg pain with SLR suggests root tension or compression. It is not specific to arachnoiditis but adds context. PubMed

4. Range-of-motion and pain-provocation — Gentle bending and extension can reproduce tether pain; limited motion also shows functional impact. PubMed

5. Pelvic floor and sphincter tone (when indicated) — In concerning cases with bowel/bladder issues, the exam may assess sacral nerve function. PubMed

B) Manual tests

1. Dermatomal sensory mapping — The examiner compares light touch and pin sensation over skin zones linked to individual roots (L4, L5, S1, etc.). Patchy changes support root involvement. PubMed

2. Myotome strength testing — Manual resistance is used to grade key muscle groups to pinpoint affected roots (e.g., ankle dorsiflexion for L4/L5). PubMed

3. Reflex testing — Patellar and Achilles reflexes help localize dysfunction; reductions may mirror adhesive root disease. PubMed

4. Neural tension tests (e.g., slump test) — Stepwise spinal flexion and leg extension increase dural tension; reproduction of radicular symptoms suggests root irritation. (General neurodynamic testing principles.) PubMed

5. Functional capacity measures — Simple timed walking or sit-to-stand tests track disability over time in chronic pain conditions. PubMed

C) Laboratory & pathological tests

1. Inflammatory markers (ESR/CRP) — Often normal in chronic disease, but may help if infection or an active inflammatory disorder is suspected. PubMed

2. Infection work-up — If fever, recent sepsis, TB risk, or immune compromise exists, targeted blood cultures or TB tests can look for causes that secondarily produce arachnoiditis. sfn.org

3. Autoimmune panels (when indicated) — Tests guided by symptoms (e.g., connective tissue disease) can support a systemic inflammatory cause. PubMed

4. CSF studies (select cases) — Lumbar puncture is rarely needed for chronic adhesive disease but may be considered if infection or unusual inflammation is suspected. PubMed

D) Electrodiagnostic tests

1. EMG/NCS (electromyography/nerve conduction) — Measures how well nerves and muscles conduct signals. It cannot “see” adhesions, but it documents root damage or chronic denervation that matches symptoms and imaging. PubMed

2. Somatosensory evoked potentials (SSEPs) — Track sensory signals from legs to brain; delays can support dorsal root involvement in complex cases. PubMed

3. Anal sphincter EMG (if severe sacral involvement) — Rarely used but can document sacral root dysfunction when bowel/bladder symptoms are prominent. PubMed

E) Imaging tests

1. Lumbar spine MRI (with/without contrast) — The main test. Doctors look for nerve root clumping, thickening, enhancement, empty thecal sac, arachnoid septations, or cysts; sometimes cord swelling, atrophy, or syrinx. NCBI+1

2. Thoracic or cervical MRI — If symptoms or prior surgery are higher up, scans of other regions can reveal multi-level disease. NCBI

3. Targeted contrast-enhanced MRI — Gadolinium may highlight active inflammation (root enhancement) or distinguish cysts/abscesses. PubMed Central

4. CT myelography — Useful when MRI is unclear or contraindicated. It can show blocked dye flow, tethered or thickened roots, soft-tissue masses, or intrathecal calcification. NCBI

5. Dynamic or positional MRI (selected centers) — Changing position can accentuate tethering effects in difficult cases; availability varies. (Specialist practice detail supported by radiology reviews.) American Journal of Roentgenology

6. Whole-spine survey MRI — Because adhesions can be multi-segment, a larger field view may detect other sites that explain symptoms. NCBI

7. Follow-up MRI for progression — Repeat imaging is not routine for every patient, but when symptoms change, new clumping or “empty sac” patterns can confirm progression. Radiopaedia

Non-pharmacological treatments (therapies & others)

Evidence note: For neuropathic pain, multidisciplinary biopsychosocial rehabilitation (team-based care combining physical re-conditioning + pain psychology + work/life supports) has the best overall support. Modalities like TENS and acupuncture have mixed/insufficient evidence for neuropathic pain specifically; I explain how to try them safely if desired. Cochrane+4BMJ+4Cochrane Library+4

1. Multidisciplinary pain-rehab program
   What it is: A coordinated program where physiotherapists, pain physicians, psychologists, and occupational therapists build one plan to help you move more, flare less, sleep better, and return to valued activities. Purpose: Reduce pain-related disability and improve quality of life even if some pain remains. Mechanism: Graded physical re-conditioning reverses de-conditioning; pain-education and CBT reduce fear-avoidance and central sensitization; pacing and goal-setting steady activity; workplace and daily-routine adjustments rebuild function. Evidence: Systematic reviews show better long-term outcomes than usual care for chronic back/neuropathic-like pain. BMJ+1

2. Graded activity & pacing
   What: Start with small, regular movement (walking, gentle core/hip work), increase by tiny steps on a schedule, not by pain spikes. Purpose: Rebuild capacity without boom-and-bust flares. Mechanism: Progressive loading improves muscle endurance and modulates pain pathways; consistent pacing lowers nervous-system “alarm.” Evidence: Core component inside biopsychosocial programs that outperform usual care. BMJ

3. Targeted physical therapy (spine-safe)
   What: Gentle mobility (hip flexors/hamstrings), neutral-spine core stabilization, balance drills, nerve-glide comfort movements (only if non-provocative). Purpose: Maintain motion and strength while protecting irritated roots. Mechanism: Improves mechanics, reduces secondary muscle spasm, and supports neural tissue health. Evidence: PT is routinely recommended; benefits are largest when combined with education and pacing. BMJ

4. Pain neuroscience education (PNE)
   What: Simple lessons about how pain works and why tissues can be sensitive even after healing. Purpose: Reduce fear and catastrophizing; increase safe movement. Mechanism: Understanding decreases threat, which can down-regulate central sensitization and improve outcomes when paired with activity. Evidence: Included within effective multidisciplinary programs. BMJ

5. Cognitive-behavioral therapy (CBT) for pain
   What: Skills to reframe unhelpful thoughts, manage flares, plan activity, and improve sleep. Purpose: Reduce distress and disability. Mechanism: Alters pain-attention and coping pathways, improving function even if pain persists. Evidence: Part of best-supported integrated care for chronic pain. BMJ

6. Mindfulness/relaxation (breath work, body-scan)
   What: Short daily practices to settle arousal. Purpose: Calm the nervous system and improve sleep. Mechanism: Lowers sympathetic drive and pain reactivity; improves emotional regulation. Evidence: Common supportive component in chronic pain pathways. BMJ

7. Sleep optimization
   What: Regular bed/wake times, dark cool room, caffeine timing, treat sleep apnea/insomnia. Purpose: Better pain thresholds and mood. Mechanism: Restorative sleep reduces central sensitization and improves pain coping. Evidence: Sleep management is a core piece of chronic pain care. BMJ

8. Assistive devices/posture ergonomics
   What: Cushions, lumbar supports, sit-stand routines, careful bending/lifting. Purpose: Reduce mechanical aggravation. Mechanism: Minimizes load on sensitive segments and roots. Evidence: Practical adaptations inside rehab plans. BMJ

9. Heat/cold self-management
   What: Brief gentle heat for muscle spasm; brief cold for acute flare. Purpose: Symptom relief and tolerance for movement. Mechanism: Modulates local blood flow and nociceptor activity. Evidence: Low-risk adjunct in chronic back pain care. BMJ

10. Nutritional anti-inflammatory pattern
    What: Plenty of vegetables/fruit, legumes, whole grains, fish/olive oil, nuts; limit ultra-processed foods and added sugars. Purpose: Support overall metabolic and nerve health. Mechanism: Reduces systemic inflammation that may worsen neuropathic pain. Evidence: Indirect but supportive for pain conditions. PubMed Central

11. TENS (trial with realistic expectations) – very low-certainty evidence for neuropathic pain overall; some benefit in diabetic neuropathy and spinal cord injury pain in small studies. If tried, use as a comfort modality, not a stand-alone treatment. American Academy of Neurology+3Cochrane+3PubMed+3

12. Acupuncture (trial only if desired) – evidence insufficient to confirm benefit for neuropathic pain; any effects may be modest and condition-specific. Cochrane+1

13. Pelvic-floor therapy for bladder/bowel dysfunction linked to sacral root irritation—can teach strategies to reduce straining and improve continence. NINDS

14. Psychological peer support/pain groups to reduce isolation and share coping strategies—often embedded in comprehensive programs. BMJ

15. Return-to-work/role rehabilitation (graded duties, breaks, ergonomic tweaks) coordinated with therapists and employer. BMJ

16. Fall-prevention and balance training if proprioception is impaired from nerve injury. NINDS

17. Smoking cessation (nicotine impairs microcirculation and healing). NINDS

18. Weight management (gradual, sustainable) to lower spine load and metabolic inflammation. NINDS

19. Flare-planning (written plan for activity changes, heat/cold, short medication adjustments approved by your clinician). BMJ

20. Safety education about injections/surgery going forward (preservative-free meds, clear indications, risk discussion). NINDS

---

Drug treatments

Evidence note: Because arachnoiditis pain is neuropathic, treatment follows neuropathic pain guidelines. Stronger evidence exists for gabapentin/pregabalin and duloxetine (for some neuropathic conditions), mixed or low-quality evidence for TCAs (amitriptyline), and targeted evidence for topical capsaicin 8% (peripheral neuropathic pain). Opioids can help some people short-term but carry significant risks and are rarely preferred long-term. Doses below are typical ranges—always individualize with your clinician, especially with kidney disease, older age, drug interactions, pregnancy, and driving/safety needs. Cochrane+4Cochrane+4PubMed Central+4

1. Gabapentin (anti-seizure for nerve pain)
   Class: α2δ calcium-channel modulator. Dose/time: Start 100–300 mg at night; titrate to 300 mg three times daily; usual effective range 1,800–3,600 mg/day in divided doses (reduce for kidney disease). Purpose: Lower abnormal nerve firing and reduce burning/electric pain. Mechanism: Binds α2δ subunit, decreasing excitatory neurotransmitter release. Side effects: Sleepiness, dizziness, imbalance, swelling; rare mood changes. Evidence: Cochrane shows benefit in several neuropathic conditions (most robust in diabetic neuropathy/post-herpetic neuralgia), with limited evidence in others; still first-line in many guidelines. Cochrane+1

2. Pregabalin
   Class: α2δ calcium-channel modulator. Dose/time: 75 mg at night, then 75 mg twice daily; target 150–300 mg twice daily (max 600 mg/day; renal adjust). Purpose/mechanism: Similar to gabapentin but more predictable absorption. Side effects: Dizziness, sleepiness, weight gain, edema, blurry vision. Evidence: Moderate-quality evidence of benefit for several neuropathic pains; inadequate for some central pains. Cochrane+1

3. Duloxetine
   Class: SNRI antidepressant. Dose/time: 30 mg daily x 1 week, then 60 mg daily (some use 60 mg twice daily). Purpose: Treat nerve pain and associated low mood/anxiety. Mechanism: Boosts spinal descending inhibition via serotonin/norepinephrine. Side effects: Nausea, dry mouth, sleep changes, sweating; caution with liver disease and drug interactions. Evidence: Effective for painful diabetic neuropathy and other chronic pain states; often first-line. Cochrane+1

4. Amitriptyline (low dose at night)
   Class: Tricyclic antidepressant. Dose/time: 10–25 mg at night; titrate to 25–75 mg (older adults often stay lower). Purpose: Help pain and sleep continuity. Mechanism: Serotonin/norepinephrine reuptake inhibition; sodium-channel and NMDA modulation. Side effects: Dry mouth, constipation, drowsiness, weight gain; avoid in significant cardiac conduction disease and glaucoma; overdose risk. Evidence: Widely used but high-quality evidence is limited; still guideline-listed with caution. PubMed+1

5. Topical capsaicin 8% patch (clinic-applied, Qutenza)
   Class: TRPV1 agonist (defunctionalizes nociceptors). Dose/time: 30–60-minute in-clinic application to painful area; can repeat every ≥8–12 weeks. Purpose: Focal relief where pain is superficial and localized. Mechanism: Causes reversible “defunctionalization” of epidermal nociceptors. Side effects: Application-site burning/redness (managed with local anesthetic/ice). Evidence: RCTs and reviews show benefit across several peripheral neuropathic pains; real-world data support repeated applications. PubMed+1

6. Topical lidocaine 5% patch/plaster
   Class: Sodium-channel blocker. Dose/time: Up to 12 hours on, 12 hours off, max 3 patches/day over painful skin. Purpose: Localized pain dampening with minimal systemic effects. Mechanism: Numbs peripheral ectopic firing. Side effects: Local rash/irritation. Evidence: Mixed/low-quality overall; may help some with localized neuropathic pain (e.g., post-herpetic neuralgia). PubMed Central

7. Low-dose naltrexone (off-label)
   Class: Opioid receptor antagonist at low dose. Dose/time: 1.5 mg at night, titrate to 4.5 mg. Purpose: Modestly reduce centralized pain and inflammation in some patients. Mechanism: Transient blockade may upregulate endogenous opioids and reduce microglial activation. Side effects: Vivid dreams, headache. Evidence: Emerging, small studies—discuss trial with a pain specialist.

8. NSAIDs/acetaminophen (supportive only)
   Class: Anti-inflammatory/analgesic. Dose/time: As tolerated, short courses for flare-related musculoskeletal pain. Purpose: Treat secondary muscle/soft-tissue pain; not primary neuropathic pain. Evidence: Limited for neuropathic pain; use as adjunct.

9. Opioids (e.g., tramadol or short trials of others)
   Class: μ-opioid agonist (tramadol also SNRI). Dose/time: Lowest effective dose, time-limited, with clear goals and risk mitigation. Purpose: Rescue option when other therapies fail; avoid long-term escalation. Risks: Dependence, sedation, constipation, endocrine effects, overdose. Evidence: Short-term benefit; long-term harms often outweigh gains—use cautiously.

10. SNRIs other than duloxetine (e.g., venlafaxine XR)
    Dose/time: 37.5–150 mg/day. Evidence: Some benefit in neuropathic pain; less robust than duloxetine. Cautions: BP elevation, withdrawal if abruptly stopped. PubMed

11. Nortriptyline/desipramine (alternatives to amitriptyline with fewer side effects; similar caveats). PubMed

12. Baclofen or tizanidine for muscle spasm secondary to guarding (not for primary nerve pain); watch sedation.

13. Clonidine topical/oral (adjunct) in specialists’ hands for sympathetically maintained components.

14. Ketamine infusions (specialist, short courses)—NMDA antagonism; can reduce severe refractory neuropathic pain; requires monitoring; benefits may be temporary.

15. Botulinum toxin injections for focal neuropathic pain syndromes; mixed evidence; consider in specialty clinics.

16. Carbamazepine/oxcarbazepine mainly for lancinating (shock-like) neuralgias; monitor sodium and drug interactions.

17. Capsaicin low-dose creams (OTC) for home spot treatment (less potent than 8% patch).

18. Topical compounded agents (e.g., lidocaine/ketamine/amitriptyline) — limited evidence; consider if standard options fail. The Open Neurology Journal

19. Alpha-lipoic acid (ALA) is a supplement but often “prescribed”—see supplement section for dosing and caveats; evidence most robust in diabetic neuropathy. AAFP

20. Treat mood, sleep, bowel and bladder issues directly (e.g., SSRIs for depression; laxatives for opioid-induced constipation; anticholinergics or pelvic-floor therapy for bladder) to improve overall quality of life—part of whole-person care. BMJ

---

Dietary molecular supplements

Evidence note: High-quality trials for arachnoiditis itself are lacking; some supplements help neuropathic pain more generally (strongest for topical capsaicin which is a medicine, and ALA—mostly in diabetic neuropathy). Use as adjuncts to rehab and first-line medicines, not as replacements.

1. Alpha-lipoic acid (ALA)
   Dose: Commonly 600 mg/day (some protocols 600–1,200 mg/day; IV forms used in trials). Function: Antioxidant that improves nerve metabolism and reduces oxidative stress. Mechanism: Scavenges free radicals; may improve microcirculation and nerve conduction. Evidence: Mixed—IV ALA shows improvements in diabetic neuropathy symptoms; oral benefits are smaller and inconsistent. Watch for GI upset and glucose-lowering interactions. PubMed Central+1

2. Omega-3 fatty acids (EPA/DHA)
   Dose: Often 1–2 g/day combined EPA+DHA (check anticoagulants). Function: Anti-inflammatory lipid mediators (resolvins/protectins). Mechanism: Modulate neuroinflammation and membrane signaling. Evidence: Human data suggest possible symptom reduction in diabetic neuropathy; stronger pre-clinical support; use as part of a heart-healthy diet. PubMed Central+1

3. B-complex (B1/B6/B12) only if deficient
   Dose: Replace confirmed deficiencies (e.g., B12 1,000 µg/day oral or injections per protocol). Function: Nerve myelin and energy metabolism. Mechanism: Corrects deficiency-related neuropathy; excess B6 can cause neuropathy—avoid high chronic doses. Evidence: Benefit when deficiency exists; not proven otherwise.

4. Acetyl-L-carnitine (ALCAR)
   Dose: 1–2 g/day in divided doses. Function: Mitochondrial support; possible nerve regeneration aid. Mechanism: Enhances acetyl-CoA transport and may support nerve fiber repair. Evidence: Mixed; some benefit shown in diabetic/chemotherapy neuropathy; may cause GI upset.

5. Vitamin D (replete if low)
   Dose: As needed to reach sufficient 25-OH-D levels under clinician guidance. Function: Immune modulation and bone health. Mechanism: May modulate inflammatory pathways, but trials for chronic pain show limited/uncertain benefit unless deficient. Evidence: Mixed/mostly negative for pain unless deficiency is present. Nature

6. Magnesium (if low)
   Dose: ~200–400 mg elemental/day, watch diarrhea and kidney disease. Function: NMDA modulation and muscle relaxation. Mechanism: May reduce central sensitization. Evidence: Limited for neuropathic pain; more for migraine/cramps.

7. Curcumin (standardized)
   Dose: 500–1,000 mg/day with piperine (interaction caution). Function: Anti-inflammatory/antioxidant. Mechanism: NF-κB and COX-2 modulation. Evidence: Small studies for pain; no arachnoiditis-specific data.

8. Gamma-linolenic acid (GLA, evening primrose)
   Dose: 240–480 mg/day. Function: Anti-inflammatory lipid. Evidence: Some benefit in diabetic neuropathy; variable quality.

9. Coenzyme Q10
   Dose: 100–200 mg/day. Function: Mitochondrial electron transport; antioxidant. Evidence: Limited; consider if statin-associated myalgias.

10. Capsaicin cream (low-dose, OTC)
    Dose: Thin layer 3–4×/day on focal areas. Function/Mechanism: TRPV1 activation → reduced local nerve firing over time. Evidence: Modest; 8% prescription patch has far stronger evidence. PubMed Central

---

Immune-modulating / regenerative / stem-cell

Important safety note: For arachnoiditis, no stem-cell product is FDA-approved, and unregulated clinics have caused serious harms (intrathecal masses, infections, neurologic worsening). If you consider regenerative options, do so only in IRB-approved clinical trials at academic centers. U.S. Food and Drug Administration+2U.S. Food and Drug Administration+2

1. Short courses of corticosteroids in acute/subacute cases (specialist-directed)
   Dose: Individualized; short high-dose tapers only when active inflammation is clear. Function: Reduce inflammatory swelling. Mechanism: Genomic anti-inflammatory effects. Evidence: Case series suggest benefit mainly early; limited role in chronic scar-dominant disease. Dove Medical Press

2. Immunotherapies for suspected autoimmune arachnoiditis (case-by-case)
   Options: IVIG, steroid-sparing agents (e.g., methotrexate) in carefully selected inflammatory phenotypes. Evidence: Sparse; consider only with neuroimmunology input.

3. Adhesiolysis/micro-lysis with fusion (surgical—see surgery section)
   Function: Mechanically release tethered roots and improve CSF flow (not biological regeneration). Evidence: Series show variable results; careful selection vital. Dove Medical Press

4. Regenerative biologics (mesenchymal stem cells, intrathecal products)
   Status: Experimental; not approved for arachnoiditis; documented serious adverse events after intrathecal injections. Action: Avoid outside trials. U.S. Food and Drug Administration+1

5. Neuromodulation (spinal cord stimulation, dorsal root ganglion stimulation)
   Function: Electrical signals modify pain transmission (not regeneration). Evidence: For refractory neuropathic pain, mixed—some RCTs (e.g., 10 kHz SCS) show benefit, while technology assessments highlight uncertainties and selection issues; consider only after comprehensive conservative care. PubMed Central+1

6. Intrathecal drug delivery pumps
   Function: Deliver medications (e.g., morphine/ziconotide) directly to CSF to reduce systemic doses. Risks: Infection, granulomas, catheter issues, and arachnoiditis has been reported after intrathecal agents. Reserve for highly selected refractory cases in expert centers. Oxford Academic+1

---

Surgeries

1. Microsurgical adhesiolysis (lysis of adhesions)
   Procedure: Carefully free tethered nerve roots and lyse arachnoid bands; sometimes combine with duraplasty or fusion. Why: To relieve focal root tethering, improve CSF flow, and reduce traction pain. Evidence: Case series report 50–80% improvement in selected patients; recurrence or new scarring is possible. Dove Medical Press

2. Shunting/CSF diversion (selected cases with obstructed CSF flow or syrinx)
   Why: Restore CSF circulation and reduce cord/root compression. Evidence: Limited to case reports/series; individualized. NCBI

3. Decompression for focal compressive pathology with arachnoiditis features
   Why: Address coexisting stenosis/disc/scar pockets adding mechanical compression. Evidence: Depends on the primary lesion; arachnoid scarring can complicate outcomes. PubMed Central

4. Endoscopic arachnoid cyst fenestration/web resection (when discrete webs/cysts drive symptoms)
   Why: Remove obstruction and tethering. Evidence: Limited series but logical when imaging and symptoms match. NCBI

5. Dorsal root ganglion (DRG) or spinal cord stimulation leads (minimally invasive neuromodulation)
   Why: For severe refractory neuropathic pain after exhaustive conservative care. Evidence: See above; patient selection crucial. PubMed Central+1

---

Prevention tips

1. Use preservative-free intrathecal/epidural drugs when indicated; avoid unnecessary spinal injections.

2. Choose experienced centers for any spinal procedures.

3. Prevent and treat spinal infections promptly.

4. Careful technique and imaging guidance for epidurals/blocks.

5. Avoid repeated traumatic punctures.

6. Discuss risks/benefits thoroughly before spine surgery; consider second opinions for complex re-operations.

7. Stop smoking; support vascular and nerve health.

8. Keep diabetes and other metabolic risks controlled.

9. ) Maintain regular gentle activity and healthy body weight. 10) Build a written flare plan with your team. NINDS

---

When to see a doctor urgently

• New or rapidly worsening leg weakness, falls, or foot drop.

• New numbness in the saddle area, or loss of bladder/bowel control.

• Fever, severe back pain, or wound issues after spinal procedures.

• Uncontrolled pain, medication side effects (confusion, severe sedation), or depression/self-harm thoughts.
  These may signal nerve compression, infection, or medication complications and need fast evaluation. NINDS

---

What to eat & what to avoid

• Eat more: Colorful vegetables and fruits; legumes; whole grains; nuts/seeds; fish (omega-3s) twice weekly; olive-oil-based meals; enough protein for muscle repair; water/unsweetened tea.

• Limit/avoid: Highly processed foods, excess added sugars, heavy alcohol, smoking, and large doses of supplements without testing (e.g., high B6).

• Why: Supports weight, heart and nerve health, lowers systemic inflammation, and fuels rehab. PubMed Central

---

FAQs

1. Is arachnoiditis permanent?
   Symptoms can be long-lasting, but many people improve function with a team program, smart medications, and pacing—even if some pain stays. Imaging changes may persist. BMJ

2. What does MRI show?
   Nerve-root clumping, thickening, empty thecal sac pattern, arachnoid webs/cysts; sometimes cord swelling or atrophy. Radiopaedia+1

3. Can medicine cure it?
   No single cure, but gabapentin/pregabalin, duloxetine, and topical capsaicin 8% can reduce nerve pain; combine with rehab. Cochrane+2Cochrane+2

4. Are steroid shots helpful?
   Spinal injections can cause or worsen arachnoiditis if not done carefully; routine epidural steroids are not a treatment for adhesive arachnoiditis itself. Discuss risks carefully. NINDS

5. Should I consider a spinal cord stimulator?
   Only after comprehensive conservative care. Evidence is mixed—some trials show benefit, but technology assessments highlight uncertainty. Selection is key. PubMed Central+1

6. Do intrathecal pumps help?
   They may help selected, refractory cases but carry risks (infection, granulomas, even arachnoiditis). Use only in expert centers. Oxford Academic+1

7. Are stem-cell treatments safe or approved?
   No approved stem-cell therapy for arachnoiditis; unregulated injections have caused serious harm. Consider trials only at academic centers. U.S. Food and Drug Administration+1

8. Can surgery fix it?
   Surgery can help when there is focal tethering or blocked CSF flow in carefully chosen cases, but results vary and scarring can recur. Dove Medical Press

9. Which supplement helps most?
   ALA has the best neuropathy data (mostly diabetic neuropathy) but benefits are modest and inconsistent; use as an adjunct. Omega-3s support general health. Test and replace true deficiencies (e.g., B12, vitamin D). AAFP+1

10. Why does pacing matter so much?
    Because boom-and-bust cycles sensitize the nervous system. Pacing builds capacity while avoiding flares. BMJ

11. Is TENS worth trying?
    Maybe—evidence is low-certainty for neuropathic pain. Safe to trial as a comfort add-on, not a core therapy. Cochrane

12. Can diet really change my pain?
    Diet alone won’t cure nerve scarring, but an anti-inflammatory pattern supports rehab, metabolic health, and possibly pain perception. PubMed Central

13. How do I prevent getting worse?
    Avoid unnecessary spinal injections/surgeries; keep moving safely; manage weight, mood, sleep; stop smoking; treat infections promptly; use preservative-free meds when needed. NINDS

14. What red flags mean “go now”?
    Worsening weakness, saddle numbness, or bladder/bowel loss; fever with spinal pain; severe new neurologic changes. NINDS

15. What’s the single most helpful step?
    Join a multidisciplinary rehab pathway while trialing first-line neuropathic pain medicines and building a personal flare plan. BMJ

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 21, 2025.